Skip to main content
Image
CKM logo reversed
CKM
Cardiology Vascular Medical Education
Register for free Log in
Cardiovascular • Kidney • Metabolic
Lifelong learning for healthcare professionals
CVRM banner
CVRM banner

Home

About

About Us Advisory Board

Topics

View AllChronic Kidney DiseaseDiabetesCardiovascular Co-morbiditiesMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Obesity

Content type

Videos Articles Broadcasts Podcasts News

Faculty

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All

Events

Upcoming Events All Events

Resource Hubs

Inflammatory Risk in CVD Rise of CVRM
  • Content for healthcare professionals only
Image
CKM logo
Register for free Log in
Back to Main Menu

View all platforms

Cardiology Vascular CKM Medical Education
  • Content for healthcare professionals only

Breadcrumb

  • Home /
  • News Index

Latest News

Tirzepatide Benefits in HFpEF Consistent Across Obesity Levels, SUMMIT Analysis Shows
Written by: Radcliffe CVRM
Tirzepatide Benefits in HFpEF Consistent Across Obesity Levels, SUMMIT Analysis Shows
28 July 2025
Heart Rate Lowering Benefits are Context-Dependent, Meta-Analysis Finds
Written by: Radcliffe Cardiology
Heart Rate Lowering Benefits are Context-Dependent, Meta-Analysis Finds
16 July 2025
Written by: Radcliffe CKM
Absence of Five Key Risk Factors at 50 Adds Over a Decade of Life
16 July 2025
Written by: Radcliffe CKM
Increased Systolic Blood Pressure Variability Over Time Linked to Higher Risk of CVD, CKD, and Death
16 July 2025
Monoclonal Antibody LY3475766 Safely Lowers Atherogenic Lipids in Phase 1 Trial
Written by: Radcliffe Cardiology
Monoclonal Antibody LY3475766 Safely Lowers Atherogenic Lipids in Phase 1 Trial
16 July 2025
Total ApoB and Lp(a) Count Deemed Superior for CAD Risk Assessment
Written by: Radcliffe CVRM
Total ApoB and Lp(a) Count Deemed Superior for CAD Risk Assessment
16 July 2025
Semaglutide 2.4 mg Achieves 63% MASH Resolution in Phase 3 ESSENCE Trial
Written by: Radcliffe CKM
Semaglutide 2.4mg Achieves 63% MASH Resolution in Phase 3 ESSENCE Trial
07 May 2025
Written by: Radcliffe CKM
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Offer Enhanced Kidney Protection, Especially in…
23 April 2025
Study Finds Multimorbidity Dramatically Increases Mortality Risk in Heart Failure Patients with Mildly Reduced and Preserved Ejection Fraction
Written by: Radcliffe CKM
Study Finds Multimorbidity Dramatically Increases Mortality Risk in Heart Failure Patients with Mildly…
27 March 2025
Written by: Radcliffe CKM
GLP-1 Receptor Agonists Reduce Risks of Dementia, Cardiovascular Disease, and Psychiatric Disorders:…
04 March 2025
  • Load More

External news

Written by: Cardiac Vascular News
Cardiac Dimensions® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour System®
08 July 2026
Written by: Cardiac Vascular News
Shape Memory Medical Completes Enrollment in Landmark AAA‑SHAPE Randomized Controlled Pivotal Trial
08 July 2026
Written by: Medscape
Rising Medication Use May Drive Lower BP, Cholesterol Risks
08 July 2026
Written by: Cardiac Vascular News
Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging
08 July 2026
Written by: Cardiac Vascular News
Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026
08 July 2026
Written by: Cardiac Vascular News
Upfront Diagnostics Announces Global Medical Advisory Board to Accelerate Efforts in Reducing Time to Stroke Care
08 July 2026
Written by: heart.org - Heart news
Do breast cancer and irregular heartbeat have common risk factors and rates?
08 July 2026
Written by: Medscape
Self-Expanding Valves Shine in Small Aortic Annuli
08 July 2026
Written by: Medscape
The Biology of a Broken Heart
08 July 2026
Written by: Medscape
Age Affects Survival and Complications After HeartMate 3
08 July 2026
  • Load More

Footer Menu 1

  • About Us
  • Our team
  • Privacy
  • Terms & Conditions
  • Contact Us
  • Radcliffe Group
  • Radcliffe Events

Footer Menu 2

  • Authors A-Z
  • Image gallery
  • Industry Partners
  • Media Partners
  • Promotional Opportunities
  • Education by Breas

Quick Links 1

  • Arrhythmia and Electrophysiology Review
  • Cardiac Failure Review
  • European Cardiology Review
  • Interventional Cardiology
  • Journal of Asian Pacific Society of Cardiology
  • US Cardiology Review

Quick Links 2

  • Arrhythmia Academy
  • Heart Failure Academy
  • Transcatheter Academy
Register for FREE
CKM Logo

Copyright® 2026 Radcliffe Medical Media. All rights reserved.

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media.

Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.